image
Innate Pharma S.A. IPHA
Healthcare - Biotechnology - NASDAQ - FR
Watchlist
$ 1.8355
-2.53 %
$ 154 M
Market Cap
-2.76
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
34.78%
EBIT Estimate
--63.76%
Net Income Estimate
69.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Innate Pharma S.A.
image
IPHA has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart IPHA

image
$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IPHA

image
$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)($100.0m)($100.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IPHA

image
$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029